Nexus AG (0FGL.L)
EUR 68.83
(0.34%)
EUR 68.83
(0.34%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 153.13 Million EUR | 45.5% |
| 2022 | 105.25 Million EUR | 0.3% |
| 2021 | 104.93 Million EUR | 5.38% |
| 2020 | 99.57 Million EUR | 7.15% |
| 2019 | 92.93 Million EUR | -10.11% |
| 2018 | 103.38 Million EUR | 114.18% |
| 2017 | 48.27 Million EUR | 10.11% |
| 2016 | 43.83 Million EUR | 7.9% |
| 2015 | 40.63 Million EUR | 25.49% |
| 2014 | 32.37 Million EUR | 9.39% |
| 2013 | 29.59 Million EUR | -10.46% |
| 2012 | 33.05 Million EUR | 48.46% |
| 2011 | 22.26 Million EUR | 43.28% |
| 2010 | 15.54 Million EUR | 32.31% |
| 2009 | 11.74 Million EUR | 7.97% |
| 2008 | 10.87 Million EUR | -0.82% |
| 2007 | 10.96 Million EUR | 14.58% |
| 2006 | 9.57 Million EUR | 44.33% |
| 2005 | 6.63 Million EUR | 4.99% |
| 2004 | 6.31 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 171.01 Million EUR | 11.67% |
| 2024 Q2 | 161.34 Million EUR | -5.65% |
| 2024 Q3 | 146.13 Million EUR | -9.42% |
| 2023 Q4 | 153.13 Million EUR | 3.39% |
| 2023 Q2 | 130.77 Million EUR | 0.91% |
| 2023 FY | 153.13 Million EUR | 45.5% |
| 2023 Q3 | 148.11 Million EUR | 13.26% |
| 2023 Q1 | 129.59 Million EUR | 23.13% |
| 2022 Q1 | 124.93 Million EUR | 19.05% |
| 2022 Q2 | 106.31 Million EUR | -14.9% |
| 2022 Q3 | 98.73 Million EUR | -7.13% |
| 2022 Q4 | 105.25 Million EUR | 6.6% |
| 2022 FY | 105.25 Million EUR | 0.3% |
| 2021 Q3 | 117.36 Million EUR | -5.64% |
| 2021 FY | 104.93 Million EUR | 5.38% |
| 2021 Q4 | 104.93 Million EUR | -10.59% |
| 2021 Q1 | 124.53 Million EUR | 25.06% |
| 2021 Q2 | 124.37 Million EUR | -0.13% |
| 2020 Q1 | 114.75 Million EUR | 23.48% |
| 2020 Q2 | 104.67 Million EUR | -8.79% |
| 2020 Q3 | 101.42 Million EUR | -3.1% |
| 2020 FY | 99.57 Million EUR | 7.15% |
| 2020 Q4 | 99.57 Million EUR | -1.82% |
| 2019 Q2 | 106.95 Million EUR | -6.2% |
| 2019 Q1 | 114.02 Million EUR | 10.29% |
| 2019 FY | 92.93 Million EUR | -10.11% |
| 2019 Q4 | 92.93 Million EUR | -4.82% |
| 2019 Q3 | 97.64 Million EUR | -8.71% |
| 2018 FY | 103.38 Million EUR | 114.18% |
| 2018 Q1 | 71.5 Million EUR | 48.13% |
| 2018 Q2 | 71.79 Million EUR | 0.42% |
| 2018 Q3 | 63.56 Million EUR | -11.47% |
| 2018 Q4 | 103.38 Million EUR | 62.64% |
| 2017 Q1 | 66.24 Million EUR | 51.11% |
| 2017 Q2 | 56.4 Million EUR | -14.86% |
| 2017 Q3 | 51.97 Million EUR | -7.84% |
| 2017 Q4 | 48.27 Million EUR | -7.14% |
| 2017 FY | 48.27 Million EUR | 10.11% |
| 2016 Q4 | 43.83 Million EUR | -14.31% |
| 2016 Q2 | 50.4 Million EUR | -9.31% |
| 2016 Q1 | 55.57 Million EUR | 36.78% |
| 2016 FY | 43.83 Million EUR | 7.9% |
| 2016 Q3 | 51.16 Million EUR | 1.51% |
| 2015 FY | 40.63 Million EUR | 25.49% |
| 2015 Q3 | 40.41 Million EUR | -13.5% |
| 2015 Q1 | 60.24 Million EUR | 86.07% |
| 2015 Q2 | 46.72 Million EUR | -22.44% |
| 2015 Q4 | 40.63 Million EUR | 0.54% |
| 2014 Q3 | 26.33 Million EUR | -0.6% |
| 2014 Q4 | 32.37 Million EUR | 22.95% |
| 2014 Q2 | 26.49 Million EUR | -22.7% |
| 2014 Q1 | 34.27 Million EUR | 15.79% |
| 2014 FY | 32.37 Million EUR | 9.39% |
| 2013 Q3 | 31.47 Million EUR | 3.53% |
| 2013 Q4 | 29.59 Million EUR | -5.97% |
| 2013 FY | 29.59 Million EUR | -10.46% |
| 2013 Q2 | 30.4 Million EUR | -14.67% |
| 2013 Q1 | 35.62 Million EUR | 7.79% |
| 2012 Q2 | 22.23 Million EUR | -15.26% |
| 2012 Q3 | 23.15 Million EUR | 4.12% |
| 2012 Q1 | 26.24 Million EUR | 17.87% |
| 2012 Q4 | 33.05 Million EUR | 42.76% |
| 2012 FY | 33.05 Million EUR | 48.46% |
| 2011 FY | 22.26 Million EUR | 43.28% |
| 2011 Q2 | 20.55 Million EUR | 4.68% |
| 2011 Q1 | 19.63 Million EUR | 26.38% |
| 2011 Q4 | 22.26 Million EUR | -0.5% |
| 2011 Q3 | 22.37 Million EUR | 8.84% |
| 2010 Q2 | 13.39 Million EUR | -12.81% |
| 2010 FY | 15.54 Million EUR | 32.31% |
| 2010 Q4 | 15.54 Million EUR | 23.78% |
| 2010 Q3 | 12.55 Million EUR | -6.24% |
| 2010 Q1 | 15.35 Million EUR | 30.76% |
| 2009 Q4 | 11.74 Million EUR | 0.0% |
| 2009 FY | 11.74 Million EUR | 7.97% |
| 2008 FY | 10.87 Million EUR | -0.82% |
| 2007 FY | 10.96 Million EUR | 14.58% |
| 2006 FY | 9.57 Million EUR | 44.33% |
| 2005 FY | 6.63 Million EUR | 4.99% |
| 2004 FY | 6.31 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cegedim SA | 629.51 Million EUR | 75.674% |
| Guerbet SA | 646.97 Million EUR | 76.331% |
| Bastide Le Confort Médical SA | 566.34 Million EUR | 72.961% |
| Revenio Group Oyj | 37.6 Million EUR | -307.271% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 91.71% |
| Sartorius Aktiengesellschaft | 6.99 Billion EUR | 97.812% |
| LNA Santé SA | 1.19 Billion EUR | 87.224% |
| Siemens Healthineers AG | 28.55 Billion EUR | 99.464% |
| Medios AG | 125.94 Million EUR | -21.587% |
| Equasens Société anonyme | 166.41 Million EUR | 7.983% |
| Stratec SE | 246.2 Million EUR | 37.802% |